Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Liabilities from Discontinued Operations (2022 - 2023)

Historic Liabilities from Discontinued Operations for Marker Therapeutics (MRKR) over the last 2 years, with Q2 2023 value amounting to $260280.0.

  • Marker Therapeutics' Liabilities from Discontinued Operations changed N/A to $260280.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $260280.0, marking a year-over-year change of. This contributed to the annual value of $7.0 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Marker Therapeutics reported Liabilities from Discontinued Operations of $260280.0 as of Q2 2023.
  • Marker Therapeutics' Liabilities from Discontinued Operations' 5-year high stood at $7.0 million during Q4 2022, with a 5-year trough of $260280.0 in Q2 2023.